Research Compounds
All compounds are lyophilized, sealed under nitrogen, and ship with batch-specific COA documentation.
BPC-157
Gastric pentadecapeptide. Widely studied for tissue repair, gut healing, and musculoskeletal recovery in preclinical models.
BPC-157 + TB-500
Synergistic recovery blend combining BPC-157 and Thymosin Beta-4 for enhanced tissue repair research.
TB-500
Thymosin Beta-4 fragment. Studied for wound healing, inflammation reduction, and tissue regeneration.
CJC-1295 + Ipamorelin
Growth hormone secretagogue blend. Studied for GH release, body composition, and recovery in research settings.
Sermorelin
Growth hormone-releasing hormone analog. One of the most studied GH secretagogues in clinical literature.
Tesamorelin
GHRH analog with extensive clinical data. FDA-approved compound studied in lipodystrophy research.
Ipamorelin
Selective GH secretagogue. Studied for targeted growth hormone release without broad hormonal disruption.
GLP-1 Semaglutide
GLP-1 receptor agonist. Extensively studied for glucose metabolism and weight management in clinical trials.
MOTS-c
Mitochondrial-derived peptide. Studied for exercise mimetic effects, metabolic regulation, and longevity.
AOD-9604
Modified hGH fragment. Studied for fat metabolism and lipolysis without affecting blood sugar or growth.
NAD+
Nicotinamide adenine dinucleotide. Central to cellular energy production, DNA repair, and aging research.
GHK-Cu
Copper peptide complex. Studied for skin remodeling, wound healing, and anti-inflammatory properties.
Selank
Synthetic Tuftsin analog. Studied for anxiolytic and nootropic effects in preclinical and clinical models.
Semax
Synthetic ACTH analog. Studied for neuroprotection, cognitive enhancement, and BDNF modulation.
PT-141
Melanocortin receptor agonist. Originally derived from Melanotan II. Studied in sexual dysfunction research.
Melanotan II
Non-selective melanocortin agonist. Studied for melanogenesis, tanning response, and appetite regulation.